Olufunmilayo Olopade to Antibodies, Monoclonal
This is a "connection" page, showing publications Olufunmilayo Olopade has written about Antibodies, Monoclonal.
Connection Strength
0.018
-
A phase I trial of the IGF-1R antibody Cixutumumab in combination with temsirolimus in patients with metastatic breast cancer. Breast Cancer Res Treat. 2013 May; 139(1):145-53.
Score: 0.018